Browse > Article
http://dx.doi.org/10.14367/kjhep.2015.32.2.65

Related factors of medication adherence in patients with dyslipidemia: The 2010-2012 Korean National Health and Nutrition Examination Survey  

Cho, Eun Jung (School of Nursing, Yeungnam University College)
Moon, Kyoung Ja (Department of Nursing, Ulsan College)
Publication Information
Korean Journal of Health Education and Promotion / v.32, no.2, 2015 , pp. 65-74 More about this Journal
Abstract
Objectives: The purpose of this study was to examine factors that influencing medication adherence in patients with dyslipidemia. Methods: Data were collected from fifth Korean National Health and Nutrition Examination Survey (2010-2012), we selected 1,992 adults aged over 30yr who participants in both health examination and health interview survey. Using the SAS 9.2 Program, data were analyzed using ${\chi}^2$-test, t-test and multiple logistic regression. Results: Medication adherence was associated with age, obesity, educational level and Health screening within 2 years. The cases with older age, obesity, higher level of education and experience of Health screening within 2 years showed significantly high medication adherence, whereas high risk group of dyslipidemia such as cardiovascular disease patients showed low medication adherence. Conclusions: Further study and strategies are needed to improve high levels of medication adherence based on factors influencing such as age, obesity, level of education and health screening experience within 2 years.
Keywords
Dyslipidemia; Medication adherence; KNHANES;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Abou-Setta, A. M., Beaupre, L. A., Jones, C. A., Rashiq, S., Hamm, M. P., Sadowski, C. A., Dryden, D. M. (2011). AHRQ Comparative Effectiveness Reviews Pain Management Interventions for Hip Fracture. Rockville (MD): Agency for Healthcare Research and Quality (US).
2 Bouchard, M. H., Dragomir, A., Blais, L., Berard, A., Pilon, D., & Perreault, S. (2007). Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol, 63(6), 698-708. doi: 10.1111/j.1365-2125.2006.02828.x   DOI   ScienceOn
3 CDC's Noon Conference. (2013). Medication Adherence. Primary care educators may use the following slides for their own teaching purpose. http://www.cdc.gov/primarycare/materials/medication/docs/medication-adherence-01ccd.pdf
4 Cho B, L. C. (2011). Current situation of national health screening systems in Korea Journal of the Korean Medical Association, 54(7), 666-669.   DOI   ScienceOn
5 Cho, H. j. (2010). A study on the prescription aspects for dyslipidemia patients in a university hospital located in Daegu. (M.S. Thesis), Department of Clinical Pharmacy Graduate School Yeungnam University, Gyeongsan. Retrieved from http://www.riss.kr/link?id=T12187366
6 Clark, A., DesMeules, M., Luo, W., Duncan, A., & Wielgosz, A. (2009). Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol, 6(11), 712-722.   DOI   ScienceOn
7 Collins, R., Armitage, J., Parish, S., Sleigh, P., & Peto, R. (2003). MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 361(9374), 2005-2016.   DOI   ScienceOn
8 Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008). Medication compliance and persistence: terminology and definitions. Value Health, 11(1), 44-47. doi: 10.1111/j.1524-4733.2007.00213.x   DOI   ScienceOn
9 De Caterina, R. (2015). The new ACCF/AHA guidelines on the treatment of dyslipidemia: pros. Intern Emerg Med, 10(2), 115-117. doi: 10.1007/s11739-014-1159-3   DOI
10 Ellis, J. J., Erickson, S. R., Stevenson, J. G., Bernstein, S. J., Stiles, R. A., & Fendrick, A. M. (2004). Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med, 19(6), 638-645. doi: 10.1111/j.1525-1497.2004.30516.x   DOI   ScienceOn
11 Foody, J. M., Joyce, A. T., Rudolph, A. E., Liu, L. Z., & Benner, J. S. (2008). Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Curr Med Res Opin, 24(7), 1987-2000. doi: 10.1185/03007990802203279   DOI   ScienceOn
12 Jun-Beom Park , Kyungdo Han, Yong-Gyu Park , Youngkyung Ko (2014). Association Between Alcohol Consumption and Periodontal Disease: The 2008-2010 Korea National Health and Nutrition Examination Survey. Journal of Periodontology;.
13 Gomez Sandoval, Y. H., Braganza, M. V., & Daskalopoulou, S. S. (2011). Statin discontinuation in high-risk patients: a systematic review of the evidence. Curr Pharm Des, 17(33), 3669-3689.   DOI
14 Han M, J. (2008). association between metabolic syndrome and coronary artery disease angiographic severity. (Master's degree), Seoul. Retrieved from http://www.riss.kr/link?id=T11216070
15 Hyun Ja Kim, Y. K., Yumi Cho , Byungyool Jun, KyungWon Oh. (2014). Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: Results from the Korea National Health and Nutrition Examination Survey, 1998-2012. International Journal of Cardiology, 174, 64-72.   DOI   ScienceOn
16 Knhanse. (2013). Community health service KCDC.
17 Lee, M. H., Kim, H. C., Ahn, S. V., Hur, N. W., Choi, D. P., Park, C. G., & Suh, I. (2012). Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005. Diabetes Metab J, 36(1), 43-55. doi: 10.4093/dmj.2012.36.1.43   DOI   ScienceOn
18 Liberopoulos, E. N., Florentin, M., Mikhailidis, D. P., & Elisaf, M. S. (2008). Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin Drug Saf, 7(6), 717-725. doi: 10.1517/14740330802396984   DOI
19 MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P., & Bond, C. A. (2005). Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging, 22(3), 231-255.   DOI   ScienceOn
20 Marcum, Z. A., Sevick, M. A., & Handler, S. M. (2013). Medication nonadherence: a diagnosable and treatable medical condition. Jama, 309(20), 2105-2106. doi: 10.1001/jama.2013.4638   DOI
21 MHW. (2013). Community health survey
22 Nam, G. E., Cho, K. H., Park, Y. G., Han, K. D., Choi, Y. S., Kim, S. M., Kim do, H. (2013). Socioeconomic status and dyslipidemia in Korean adults: the 2008-2010 Korea National Health and Nutrition Examination Survey. Prev Med, 57(4), 304-309. doi: 10.1016/j.ypmed.2013.06.008   DOI   ScienceOn
23 NIH. (2002). Detection, Evaluation,and Treatmentof High BloodCholesterol in Adults(Adult Treatment Panel III) (L. National Cholesterol Education Program National Heart, and Blood Institute, Trans.).
24 Okamura, T. (2010). Dyslipidemia and Cardiovascular Disease: A Series of Epidemiologic Studies in Japanese Populations. J Epidemiol, 20(4), 259-265.   DOI
25 Rae, L. N. (2012). Factors of Taking a Health Examinatio. (master's degree), Korea University Seoul. Retrieved from http://www.riss.kr/link?id=T12868078
26 Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Turner, M. B. (2012). Executive summary: heart disease and stroke statistics 2012 update: a report from the American Heart Association. Circulation, 125(1), 188-197. doi: 10.1161/CIR.0b013e3182456d46   DOI
27 Toth, P. P. (2008). Subclinical atherosclerosis: what it is, what it means and what we can do about it. Int J Clin Pract, 62(8), 1246-1254.   DOI   ScienceOn
28 Wang, S., Xu, L., Jonas, J. B., You, Q. S., Wang, Y. X., & Yang, H. (2011). Prevalence and associated factors of dyslipidemia in the adult Chinese population. PLoS One, 6(3), e17326. doi: 10.1371/journal.pone.0017326   DOI   ScienceOn
29 Zambon, A. (2015). The new ACC/AHA guidelines on the treatment of dyslipidemia: cons. Intern Emerg Med, 10(2), 119-122. doi: 10.1007/s11739-014-1165-5   DOI   ScienceOn
30 WHO. (2003). Adherence to Long-Term Therapies-Evidence for Action [Internet]. http://apps.who.int/medicinedocs/en/d/Js4883e/ (1 January 2014